Ernexa Therapeutics (ERNAW) FCF Margin (QoQ) (2010 - 2024)
Powered by 
Analysis
Ernexa Therapeutics (ERNAW) FCF Margin (QoQ) (2010 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Ernexa Therapeutics | 67,312.70 | 67,312.70 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -1.74 Mn |
| Sep 30, 2024 | 404,171.00 |
| Jun 30, 2024 | 285,106.00 |
| Mar 31, 2024 | -668,519.00 |
| Dec 31, 2023 | 1.47 Mn |
| Dec 31, 2020 | 2,247.00 |
| Mar 31, 2020 | -9,582.00 |
| Dec 31, 2019 | 1,349.00 |
| Sep 30, 2019 | -135.00 |
| Jun 30, 2019 | -353.00 |
| Mar 31, 2019 | -72.00 |
| Dec 31, 2018 | 913.00 |
| Sep 30, 2018 | -206.00 |
| Jun 30, 2018 | 805.00 |
| Mar 31, 2018 | 710.00 |
| Dec 31, 2017 | 2,481.00 |
| Sep 30, 2017 | -9,270.00 |
| Jun 30, 2017 | 6,700.00 |
| Mar 31, 2017 | -1,185.00 |
| Dec 31, 2016 | 239.00 |